by
John R. Fischer, Senior Reporter | November 02, 2021
Siemens has built a factory in Germany for the production of X-ray tubes and generators
Siemens Healthineers has built a 57,000 square-meter High Energy Photons Center (HEP) in Forchheim, Germany for €350 million (~$400 million). The facility, which is scheduled to go into operation in 2023, will become the site of production, research, development and logistics for X-ray tubes and generators used in its medical imaging scanners.
It is the largest single investment in new construction made by Siemens Healthineers, and the components from the center will be the primary parts in its CT, angiography and X-ray equipment. The factory will have highly automated equipment to reduce production costs, increase product quality and have space for further expansion.
“With the High Energy Photonics Center, we are now creating one of the most modern and sustainable facilities for the development and production of medical technology components in Europe and beyond," said Bernd Montag, CEO of Siemens Healthineers, in a statement. "As a global company, this milestone in our history also underlines our commitment to Germany and Bavaria as a technology center,"
Ad Statistics
Times Displayed: 174148
Times Visited: 3178 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
The HEP center will be the first Siemens Healthineers factory with a complete end-to-end digitalization approach for the entire life cycle of each product. The development department will create a digital twin for each solution and transmit the data into production. This will save on cost, quality and transparency and optimize the entire manufacturing process.
The building is the size of eight soccer fields and offers space for around 700 workplaces. It is designed with a specially developed energy concept that enables it to be almost CO2-neutral.
Siemens recently
invested $32 million stateside to boost manufacturing at its Glasgow Laboratory Diagnostics Manufacturing Facility in Delaware for its diagnostics supply chain. The investment will allow the company to add on production of more than 20 new in vitro diagnostic assays over the span of 24 months. The facility is one of several under Siemens Healthineers that manufactures solutions for its diagnostics division, making over 120 assays that run on the Atellica Solution, ADVIA Chemistry Dimension, Dimension VIsta, Syva Drug Testing and Status CS instruments.
